抗肿瘤PD-1和PD-L1治疗现状与免疫相关不良反应的机制探索
杨蕾伊, 林桑, 谢其冰, 尹耕
Current Status of PD-1/PD-L1 Anti-tumor
Therapy and Exploration of the Mechanism of Immune-related Adverse Events
YANG Leiyi, LIN Sang, XIE Qibing, YIN Geng
中国全科医学
.
2022, (11): 1393
-1398
.
DOI: 10.12114/j.issn.1007-9572.2021.01.312
